Rationale for the Use of Combination Injectable Therapy in Patients With Type 2 Diabetes Who Have High A1C (≥9%) and/or Long Duration (>8 Years): Executive Summary

Detalles Bibliográficos
Autores principales: Fonseca, Vivian A., Sood, Minisha, Galindo, Rodolfo J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2021
Materias:
Clinical Diabetes Digital Publication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061553/
https://www.ncbi.nlm.nih.gov/pubmed/33986566
http://dx.doi.org/10.2337/cd20-0121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061553/
https://www.ncbi.nlm.nih.gov/pubmed/33986566
http://dx.doi.org/10.2337/cd20-0121

Ejemplares similares